DRKS00030400
Recruiting
Phase 4
Pilot study to evaluate glycemic control using GlucoTab in combination with continuous glucose monitoring in non-critically ill patients with type 2 diabetes at the general ward - GlucoMenDay_GlucoTab
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- E11
- Sponsor
- Medizinische Universität Graz
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Informed consent obtained after being advised
- •of the nature of the study
- •\-Male or female aged \=18 years
- •\-Type 2 diabetes (treated with diet, oral agents,
- •non\-insulin injected anti\-diabetic medicine,
- •insulin therapy or any combination of the four)
- •or newly diagnosed hyperglycemia which
- •requires s.c. insulin therapy
Exclusion Criteria
- •\- Type 1 diabetes, gestational diabetes
- •\- Any disease or condition which the
- •investigator or treating physician feels would
- •interfere with the trial or the safety of the
- •\- Hyperglycaemic episodes (ketoacidosis,
- •hyperosmolar state) if they require intravenous
- •insulin therapy
- •\- Pregnancy
- •\- Any mental condition rendering the patient
- •incapable of giving his consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Pilot study to evaluate glycemic control with GlucoTab using an ultra-long acting insulin analogue in non-critically ill patients with type 2 diabetes at the genaral ward - GlucoTab_DegludecDiabetes Mellitus Type 2, HyperglycaemiaTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2018-002646-36-ATMedical University of Graz30
Not yet recruiting
Phase 4
Pilot study to evaluate glycemic control with GlucoTab using an ultra-long acting insulin analogue in non-critically ill patients with type 2 diabetes at the general wardE11Type 2 diabetes mellitusDRKS00015119niv.-Klinik für Innere MedizinKlinische Abteilung für Endokrinologie und Diabetologie30
Completed
Phase 4
Pilot study to evaluate glycemic control withGlucoTab using an ultra-long acting insulinanalogue in non-critically ill patients with type 2diabetes at the general wardE11Type 2 diabetes mellitusDRKS00011487niversitätsklinik für Innere Medizin, Abteilung für Endokrinologie und Diabetologie30
Completed
Phase 4
Exploratory study to assess blood sugar control through the continuous use glucose monitor in patients with type 2 diabetes treated with basal insulin randomized to insulin glargine 300u / ml or glargine 100 u / ml been a 21 week single site study open with parallel armsRBR-35nvnjCPCLIN - Centro de Pesquisas Clinicas LTDA
Not yet recruiting
Phase 3
Comparison of efficacy and safety of different doses of metformin in women with gestational diabetes mellitusCTRI/2023/11/059803All India Institute of Medical Sciences New Delhi